Four Major Approval Decisions To Watch Out For In Q2

 
• By Ayisha Sharma

Having looked at four prominent drug candidates which are expecting important top-line data this quarter, with the help of Biomedtracker's Q2 Outlook Report, we take a look at four other assets that could soon break into the US market, from infectious diseases to diabetes.

Exterior view of the headquarters of US Food and Drug Administration (FDA). This federal agency approves medication.
These Four Drug Candidates Have A PDUFA Date Set By The FDA • Source: Alamy

More from New Products

More from Scrip